Hemophagocytic syndrome (HPS) is an unrecognized complication occurring in the acute stage of human immunodeficiency virus (HIV) infection that is seldom reported in the literature. We herein present a case of HPS that occurred during the seroconversion stage of HIV infection. In this case, pancytopenia and liver dysfunction related to HPS recovered after the initiation of antiretroviral therapy (ART). This report indicates the importance of early recognition of HPS and suggests that prompt initiation of ART has the potential to control HPS in the acute stage of HIV infection.
Introduction
Virus-associated hemophagocytic syndrome (VAHS) is a rare but potentially life-threatening disease. The Epstein-Barr virus (EBV) is the leading trigger of VAHS, and human immunodeficiency virus (HIV) is an additional causative agent of hemophagocytic syndrome (HPS). Thus far, most cases of HIV-associated HPS have been reported in patients with advanced HIV stages, during which the patients also suffered from concomitant infections or malignant diseases. The mortality rate of HPS patients in the pre-antiretroviral therapy (ART) era was reported to be 50-100% (1, 2) . Even in the highly active anti-retroviral therapy (HAART) era, the death rate of HPS patients with advanced stages of HIV reaches 31%. The common causes of HPS in advanced stages are opportunistic infections such as tuberculosis or cytomegalovirus (1) . Early recognition is essential in order to obtain a favorable outcome for patients with HPS associated with HIV infection. However, the entire picture of HPS associated with HIV, in particular, HPS associated with acute HIV infection, is incomplete. The direct role of HIV as a causative agent of HPS remains to be determined. We herein report the case of an HPS patient with acute HIV infection who completely recovered from HPS following ART. This case provides a clue to the pathophysiology of HPS associated with acute HIV infection and suggests that the early initiation of ART is associated with a favorable outcome.
Case Report
In mid-September 2010, a 48-year-old Japanese man visited a local hospital due to fever, chills and a sore throat lasting five days. He presented with a non-pruritic erythematous rash on the trunk and extremities. Empirical antibiotic therapy with cefotaxime sodium was administered; however, the fever persisted. The patient developed leukocytopenia, thrombocytopenia and abnormal liver function tests. He was referred to our hospital for a work-up fifteen days after the first visit to the local hospital. At admission, the patient developed oral candidiasis. However, he was apparently well oriented, and there were no remarkable findings on his physical examination, except for erythematous oral pharynx. The patient had no significant hepatosplenomegaly. His 1,090 U/mL. Neither pleocytosis nor elevated protein concentrations were found on a cerebrospinal fluid examination. The patient denied intravenous drug use but admitted to having occasional unprotected sexual intercourse with men one month prior to presentation. Screening for the HIV antigen/antibody test was positive, and a Western-blot (WB) analysis showed positivity for p24 proteins only and was scored as indeterminate. The patient's HIV-RNA level, CD4 T-cell count and CD8 T-cell count were 3,000,000 copies/ mL, 98 cells/μL and 276 cells/μL, respectively. The presentation was consistent with that of a primary infection of HIV. Since acute HIV infection is generally a self-limited illness, we did not administer any specific treatments and instead carefully observed the patient's condition. The patient's entire clinical course is shown in Fig. 1 . On the 13th day of hospitalization, the patient complained of right lower quadrant abdominal pain with tenderness, and the highgrade fever (39 ) relapsed. Radiological examinations performed on that day revealed no specific findings. The laboratory results obtained on the 20th day of hospitalization showed that the leukocytopenia, mild anemia, thrombocytopenia and levels of ALT, LDH and ferritin were progressively elevated (Fig. 1) . The patient's fasting triglyceride level was also elevated to 332 mg/dL. A bone marrow biopsy was performed as one of the diagnostic procedures. A pathological examination of the bone marrow revealed normal cellularity with histiocyte infiltration and hemophagocytosis; however, no evidence of malignant cells was observed (Fig. 2) . The hemoglobin level decreased to 8.0 g/dL. The findings (fever, bicytopenia, hypertriglyceridemia, hyperferritinemia and hemophagocytosis in the bone marrow) fulfilled the diagnostic criteria for HPS (3) . The results of serological tests for other viral infections are shown in Table. The results showed that the patient had been previously in- (Fig. 1) . However, the patient developed acute renal failure one week after the initiation of ART. The liver failure was suspected to have been caused by tenofovir (Fig. 1) . We subsequently discontinued the ART and carefully observed the patient's condition. Ten days after the discontinuation of ART, the high-grade fever relapsed and ART consisting of abacavir/lamivudine (ABC/3TC) and RAL was resumed. The patient's fever promptly subsided. The CD4 T-cell count rapidly increased to 689 cells/μL after four weeks of ART and remained stable thereafter. The HIV-RNA level showed a progressive decline and became undetectable six months after the initiation of ART. The patient has remained on ART and has never exhibited any clinical signs of HPS recurrence. Eleven months after the initial examination, the results of HIV WB, which showed the reactive bands of p 24, gp120 and gp160, were found to be positive.
Discussion
Hemophagocytic syndrome, also called hemophagocytic lymphohistiocytosis (HLH), is a rare disease caused by a dysfunction of cytotoxic T-cells and natural killer (NK) cells. Impaired activity of NK cells and cytotoxic T-cells leads to cytokine dysregulation with proliferation and activation of histiocytes. Among the causes of secondary HPS, viral infection is the leading trigger for the abnormal functioning of macrophages. Any virus can cause HPS, although EBV is the most common causative agent. HIV itself can also be a causative agent of secondary HPS.
Since acute HIV infection is generally a self-limited illness, most clinicians do not administer any specific treatments for acute HIV infection, although controversy regarding this issue still exists. Persistent fever, splenomegaly and cytopenias, which are included in the diagnostic criteria of HPS, are often observed in HIV-infected patients in the seroconversion stage. Therefore, HPS is often underdiagnosed in acute HIV patients. High-dose corticosteroids are commonly used in the HIV-negative HPS setting; however, the use of high-dose corticosteroids to treat acute HIV infections remains highly controversial, as these drugs can promote HIV replication. In the present case, we were confronted with rapid disease progression and we made a decision to initiate ART. Subsequent to the administration of ART, the patient improved substantially. We would therefore like to propose that the administration of ART is viable a treatment option for HPS patients with acute HIV infections.
To the best of our knowledge, only seven cases of HPS associated with acute HIV infection have so far been reported in the English literature (4) (5) (6) (7) (8) . In contrast to the later stages of HIV infection, the prognosis of HPS patients with acute HIV infections seems favorable. Indeed, all of the eight patients reported previously achieved complete recovery from HPS after the administration of ART or supportive therapy such as intravenous immunoglobulin or steroids. Of eight cases, four involved the administration of ART during acute HIV infection. The significant difference observed between the prognosis of HPS patients with acute HIV infection and that of HPS patients in advanced stages of HIV might be related to the CD4 T-cell count at the time of HPS diagnosis, as worse outcomes are observed in patients with CD4 T-cell counts less than 200 cells/μL (1) .
Although HPS itself can be the cause of acute renal failure, in this case, the renal dysfunction was strongly suspected to be associated with TDF (9) . The patient's renal dysfunction quickly improved following a temporal discon-tinuation of ART and did not recur after resuming ART with an alternative regimen that did not include TDF. Among seven previously reported acute HIV-HPS cases, only one was complicated by acute renal failure, and that patient did not receive ART.
Six of the eight reported cases of acute HIV-HPS occurred in East Asia (Taipei, Korea and Japan (our case)). Of note, EBV-associated HPS also has a high incidence in the Far East. Although the precise mechanism underlying this phenomenon remains unclear, the presence of a pathogenic EBV strain in these countries is suspected (10) . A specific polymorphism related to tumor necrosis factor (TNF)-α has been reported to be associated with increased susceptibility to secondary HPS in the Korean population (11) . Regarding HIV strains, the presence of pathogenic HIV strains associated with HPS in these countries is unconfirmed. The fact that identical HIV strains were isolated from an acute HIV-HPS patient and an asymptomatic partner suggests that host genetic factors, rather than viral pathogenesis, may affect the occurrence of HPS in patients with acute HIV infections (5) .
In this report, we highlight HIV as a causative agent of HPS and propose that ART may be effective in controlling acute HIV-HPS. Clinicians should therefore bear in mind that the prompt initiation of appropriate ART has the potential to control acute HIV-HPS.
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